Atlas Venture
25 First Street
Suite 303
Cambridge, MA 02141
United States

Open map

Recent investment activity

KANDO id: 24121

Corporate information

Registration country

Funding rounds

Top investment portfolio themes

Actual initial investment stage
N/A (53)
Series A (27)
Seed (9)
Other (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 25 of 115
Profile Country Date Funding
3V Transaction Services Ltd Pay-as-you-go credit card voucher company. Series A Initial investment
Abine Inc An online consumer privacy company that allows people to browse the web while keeping their identity safe. Series A Initial investment 5,000,000 (USD 5,000,000)
Achillion Pharmaceuticals Inc Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. N/A Initial investment
Active Endpoints Inc Business process management software. Series A Initial investment
Adnexus Therapeutics Inc A biotechnology company focused on developing new class of therapeutic compounds. N/A Initial investment
AdSafe Media Inc Provider of online advertising brand protection and risk management solutions in the United States and Europe. N/A Follow-on investment
AdSafe Media Inc Provider of online advertising brand protection and risk management solutions in the United States and Europe. Series B Initial investment led the round
Advanced Electron Beams Inc (AEB) Provider of electron beam energy technology products and solutions worldwide. Series C Initial investment 14,200,000 (USD 14,200,000)
Alnylam Pharmaceuticals Inc N/A Initial investment
Apogee Photonics Inc N/A Initial investment
Arbor Networks Inc DDoS attack prevention, network security and visibility solutions company. N/A Initial investment
Archemix Corp A biotechnology company, engages in discovering, developing, and commercializing aptamer therapeutics for the treatment of life threatening diseases. N/A Initial investment
Arteaus Therapeutics LLC A product-focused biotechnology company developing a novel treatment for migraine prevention. N/A Initial investment 18,000,000 (USD 18,000,000)
Avila Therapeutics Inc A biotechnology company, pioneering a method to discover and develop new small-molecule medicines that achieve 'protein silencing'. Series A Initial investment 21,000,000 (USD 21,000,000)
Bicycle Therapeutics Ltd A biotechnology company developing a novel technology platform for the creation of a new generation of biotherapeutics. Seed Initial investment
Bit9 Inc Market leader in adaptive application whitelisting. Series A Initial investment 6,000,000 (USD 6,000,000)
Castle Networks Inc N/A Initial investment
Cellzome AG A drug discovery and development company and a leader in the use of chemical proteomics technologies. Series C Initial investment 30,000,000 A Los Angeles-based video startup, started off as a platform that allowed users to curate video playlists in real time Seed Initial investment 1,500,000 (USD 1,500,000)
CloudSwitch Inc Provider of innovative software appliance that empowers an enterprise. Series A Initial investment 7,400,000 (USD 7,400,000)
CytoMed Inc A biotechnology company, engages in the discovery, development, and commercialization of pharmaceuticals to treat inflammation. N/A Initial investment
Dailymotion SA A web video portal for members to see, create, and share online videos. Series A Initial investment 9,500,000 (USD 9,500,000)
DataPower Technology Inc N/A Initial investment
DataXu Inc Provider of the leading real-time media management platform for digital advertising campaigns across online, mobile and video channels. Series A Initial investment 7,800,000 (USD 7,800,000)
DisplayLink Corp Developer of USB graphics technology designed to connect computers and displays using USB and Wireless USB. Series D Initial investment 15,000,000 (USD 15,000,000)

Selected Products / Customers